Bijoy Hans Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2026 ,inter alia, to consider and approve To consider & approve the Audited ....
Awaiting price reaction for this filing.
Bijoy Hans Ltd has scheduled a Board Meeting on May 28, 2026 to consider and approve the Audited Financial Statements (Standalone and Consolidated) for Q4 and the year ended March 31, 2026, along with the Auditors Report. The trading window for insiders remains closed from April 1, 2026 till May 30, 2026. Note: The letter is signed by Kaushal Shah, Managing Director of Arvaya Healthcare Limited, which may indicate a corporate name change or restructuring. This is a standard prior intimation notice under SEBI Listing Regulations, but does not contain any financial results or material disclosures.
This is a routine procedural filing and does not contain any material information about the company's financial performance. The actual impact on shareholders will only be known when the audited financial results are disclosed after the board meeting.